## **Core Concept**
The question pertains to coagulation defects associated with an increased risk of thrombosis, which involves an imbalance in the coagulation and anticoagulation pathways. This imbalance can lead to a prothrombotic state.

## **Why the Correct Answer is Right**
The correct answer, **D. Protein C resistance**, is associated with an increased risk of thrombosis. Protein C resistance, most commonly caused by the Factor V Leiden mutation, leads to a reduced response to activated protein C (APC). APC normally helps regulate coagulation by inactivating Factors Va and VIIIa. When there's resistance to APC, the coagulation pathway becomes overactive, leading to an increased tendency to form thrombi.

## **Why Each Wrong Option is Incorrect**
- **Option A: ↑ Protein C**. Increased levels of protein C would actually enhance anticoagulation, reducing the risk of thrombosis, not increasing it.
- **Option B: ↑ Protein B**. There seems to be a confusion here as there's no well-known coagulation factor or regulatory protein specifically named "Protein B" in the context of coagulation disorders related to thrombosis.
- **Option C: ↑ Anti Thrombin III (AT III) or HE (likely a typographical error for AT III)**. Increased levels of antithrombin III would enhance anticoagulation, thereby decreasing the risk of thrombosis.
- **Option E: Dysfibrinogenemia**. This condition involves abnormal fibrinogen, which can lead to either bleeding or thrombotic tendencies, but it's not characteristically associated with increased coagulation in the same direct way as protein C resistance.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **Factor V Leiden** mutation is a common cause of inherited thrombophilia, leading to **protein C resistance**. This condition increases the risk of venous thromboembolism. Testing for Factor V Leiden is considered in patients with recurrent or familial thrombosis.

## **Correct Answer: D. Protein C resistance**